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The leaf MeOH extract of Psychotria leiocarpa (Rubiaceae) showed in vitro non-cytotoxic and 
anti-dengue virus serotype 2 (DENV2) activity in human hepatocarcinoma cell lineage (HepG2). A 
one-step and cost-effective reversed-phase solid-phase extraction method based on high-performance 
liquid chromatography (HPLC) parameters allowed the isolation, directly from this bioactive 
extract, of the monoterpene indole alkaloids: N-glucopyranosyl vincosamide (1), vincosamide (2) 
and strictosidinic acid (3). The chemical structures were characterized based on 1D and 2D nuclear 
magnetic resonance (NMR), UV and high-resolution mass spectra (HRMS). The methodology 
has also allowed yielding a polyphenolic-rich fraction that was analyzed by high-performance 
liquid chromatography coupled to diode array detection and electrospray ionization tandem mass 
spectrometry (HPLC-DAD-ESI-MS/MS) revealing two flavonol triglycosides (4, 5) and three 
caffeoylquinic acid isomers (6-8). Compound 3 is reported for the first time in P. leiocarpa and all the 
phenolic compounds (4-8) are described for the first time in the genus Psychotria. Compounds 1-3 
showed to be non-cytotoxic and anti-dengue active towards DENV2, highlighting vincosamide (2). 
Keywords: Psychotria leiocarpa, Rubiaceae, monoterpene indole alkaloids, phenolic 
compounds, solid-phase extraction, anti-dengue activity
Introduction
Psychotria L. is the largest genus in the Rubiaceae 
family with near to 13000 species worldwide, mostly 
distributed in tropical regions.1 The phytochemical studies 
of the Psychotria spp. described so far have allowed 
identifying the genus as a source of alkaloids, terpenoids, 
steroids, flavonoids, tannins, cyclopeptides and phenolic 
compounds which may be related to the wide variety of 
biological activities revealed to those species, such as: 
cytotoxicity, analgesic, antiviral, antifungal and modulator 
of the activity of the central nervous system.2,3 The species 
Psychotria leiocarpa Cham. & Schltdl grows as a shrub, 
being native in Argentina, Paraguay, and Brazil, and in the 
latter, it can be found in the Northeast and Southern regions.4 
Extracts from its leaves collected in different locations of the 
Brazilian territory have been reported as antioxidant, anti-
inflammatory, inhibitor of the acetylcholinesterase enzyme, 
antitumoral, analgesic and antimycobacterial.5-9 From this 
species were isolated or characterized, iridoid glucosides, 
cyclotides, sesquiterpenes (from its essential oil) and 
the monoterpene indole alkaloids N,β-D-glucopyranosyl 
vincosamide (1) and vincosamide (2).6,10-13 Compound 1, 
described as the major alkaloid in its leaves, presents 
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a broad antioxidant activity, which was considered to 
be possibly associated to the species protection against 
oxidative stress such as wounding and UV exposure.12,14,15 
Compound 2 demonstrates anti-inflammatory activity and 
inhibition of the enzyme acetylcholinesterase.6 
Dengue is a neglected disease widespread throughout 
the tropical and subtropical areas and its incidence has 
dramatically increased in the last decades.16 The World 
Health Organization (WHO) estimates that dengue virus 
(DENV) infects about 390 million people annually.16 It is 
being considered one of the most prevalent viral infections 
in the world.17,18 In Brazil, it is placed among one of the most 
serious public health issues.19 Currently, there is no antiviral 
drug approved for the routine treatment of dengue patients. 
Thus, the discovery of drugs that can exert antiviral activity 
against DENV, without being toxic to the host cell is highly 
desirable. Natural products are one of the most important 
sources for the development of new drugs20 and some potential 
anti-dengue natural compounds have been described.21  
The solid-phase extraction (SPE) is a technique that 
has been increasingly used in numerous fields due to its 
simplicity, cost-effectiveness, and easiness of automation. 
SPE permits an efficient separation, concentration, and/or 
pre-purification of analytes and, in semi-preparative or 
preparative scales it can be advantageous because of its 
reduced time of analysis, low solvent consumption and 
possibility of preparing multiple samples simultaneously.22-25 
As part of our ongoing search for potential anti-dengue 
agents, the in vitro antiviral activities of several Brazilian 
Rubiaceae spp. and some of their compounds have been 
described.25-30 In this paper, we report the in vitro non-
cytotoxicity and anti-dengue virus serotype 2 (DENV2) 
effects in hepatocarcinoma cell lineage (HepG2), of the 
crude MeOH extract of P. leiocarpa leaves and of the 
monoterpene indole alkaloids N,β-D-glucopyranosyl 
vincosamide (1), vincosamide (2) and strictosidinic acid (3) 
isolated by a developed one-step reversed-phase SPE 
method based on high-performance liquid chromatography 
(HPLC) conditions. The methodology has also allowed 
yielding a polyphenolic-rich fraction which was analyzed 
by online high-performance liquid chromatography coupled 
to diode array detection and electrospray ionization tandem 
mass spectrometry (HPLC-DAD-ESI-MS/MS) revealing 




Methanol (MeOH) and acetonitrile (ACN), both 
HPLC grade, were purchased from Tedia (Rio de Janeiro, 
Brazil). Dimethyl sulfoxide (DMSO) was purchased 
from Romil Chemical Ltd. (Cambridge, UK). Water was 
purified in a Milli-Q system (Millipore, St. Louis, USA). 
Formic acid (HCOOH) (analytical grade) was acquired 
from Vetec (Rio de Janeiro, Brazil) and glacial acetic 
acid (AcOH) (analytical grade) from Merck (Frankfurt, 
Germany) or Vetec (Rio de Janeiro, Brazil). The thin 
layer chromatography (TLC) analyses were performed 
in pre-coated silica gel 60 F254 plates (Merck, Frankfurt, 
Germany) using buthanol (BuOH) (Nuclear, São Paulo, 
Brazil)/AcOH/water (H2O) (40:10:10 v/v/v as mobile phase 
and irradiation under 254 and 365 nm, and/or NP reagent 
(diphenylboric acid β-aminoethyl ester) (Sigma-Aldrich, 
St. Louis, USA) followed by irradiation under 365 nm, 
and/or anisaldehyde/sulfuric acid (H2SO4) (Sigma-
Aldrich, St. Louis, USA and Vetec, Rio de Janeiro, Brazil, 
respectively) to visualize the spots. Nuclear magnetic 
resonance (NMR) spectra were recorded in CD3OD 
(Cambridge Isotope Laboratories Inc., Tewksbury, USA) 
in Varian System 500 spectrometer (Varian Inc., Palo Alto, 
USA) using the solvent as internal standard. Chemical shifts 
(d) are given in ppm and coupling constants (J) in Hz. High 
resolution mass spectra (HRMS) of the isolated alkaloids 
were performed in Bruker TOF-maXis spectrometer 
(Bruker Corp, Billerica, USA). The samples were analyzed 
in positive ion mode solubilized in MeOH at 1 mg mL-1. 
Phenolic standards were supplied as previously described.30 
All stock standard solutions, in concentrations ranging 
from 300 to 2700 μg mL-1, depending on each phenolic 
compound, were prepared in MeOH. All solutions were 
stored at 4 ºC in darkness.
Plant material
The species Psychotria leiocarpa was collected in 
May 2014 at the Parque Nacional da Serra dos Órgãos, 
in the municipality of Guapimirim, Rio de Janeiro State, 
Brazil. Voucher specimen was deposited at the Herbarium 
of the Universidade Federal do Rio de Janeiro, RJ, Brazil, 
under number RFA 40646. The collection had the previous 
permission from SISBIO-ICMBio-MMA-Brazil under 
number 46504-2. Legal access of the Brazilian genetic 
heritage component is registered in the SisGen platform 
under number A9C4B8A.
Extraction and partition
P. leiocarpa leaves were dried at 40 °C for 24 h, milled 
and sieved at ≤ 2.00 mm particle size. Two different batches 
of extract were obtained from the dried leaves: first 4.9 g 
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were sonically extracted at room temperature (15 min 
each cycle) with MeOH (6 × 75 mL) and second 9.45 g 
were extracted similarly with MeOH (10 × 100 mL). The 
solvents were evaporated under low pressure, yielding 
284.6 and 681.1 mg of dried crude extracts, respectively. 
The TLC alkaloid profiles of the extracts were identical. 
The first batch (284.6 mg) was defatted by dissolving it 
in 40 mL of MeOH/H2O 1:3 (v/v) and partitioning with 
hexane (10 × 40 mL). The solvents were removed under 
low pressure yielding 14.6 and 202.8 mg of the hexane and 
hydromethanolic fractions, respectively. 
HepG2 infection and treatment
Human hepatocarcinoma cell lineage (HepG2) cells were 
grown in Dulbecco’s modified Eagle’s medium (DMEM) 
(LGC Biotecnologia, Cotia, Brazil) supplemented with 10% 
fetal bovine serum (FBS), at 37 °C, in an atmosphere of 5% 
CO2. HepG2 cells were infected with DENV-2 (strain 16681) 
in multiplicity of infection (M.O.I.) of 1 for 1 h at 37 °C in 
5% CO2. After infection, the medium was replaced by fresh 
medium (DMEM with 5% FBS) with or without 50 μg mL-1 
(in DMSO) of the crude extract or the pure compounds 
(vincosamide (2) was also tested at 25 μg mL-1) and cultured 
at 37 °C in 5% CO2. The samples (stock 100 μg μL-1) were 
added to the medium (DMEM with 5% FBS) to obtain the 
desired concentration. The final concentration of DMSO 
in HepG2 culture was 0.05%, which was also added to the 
infected and untreated condition. After 48 h of infection, the 
culture medium was collected for virus quantification by 
plaque assay and cellular extracts were used to determine 
viability (as described below). 
Cell viability assay 
The effect of the samples in infected HepG2 cell 
viability was determined by measuring the metabolization 
of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT metabolization assay) by the cells. Cells 
seeded in a 24-well plate were infected with DENV-2 
and treated as previously described. Cytotoxicity and/or 
proliferative effects were assessed treating uninfected 
HepG2 cells in the same conditions. Forty-eight hours-post 
infection cells were washed with balanced salt solution 
(BSS) prior to the addition of 500 μL of 0.5 mg mL-1 MTT 
(Sigma-Aldrich, St. Louis, USA) in BSS to each well. 
After 1 h, MTT solution was discarded and the formazan 
crystals formed were solubilized in each well using 500 μL 
of 0.04 M HCl solution in iso-propanol (iPrOH). The optical 
density (OD) of the samples was read at 570 and 650 nm 
for background correction.
Virus quantification 
The virus titer in the culture medium of infected HepG2 
cells was quantified by plaque assay in baby hamster kidney 
cells (BHK-21 cells). Briefly, BHK-21 cells were grown in 
minimum essential medium (α-MEM)  (Invitrogen, Life 
Technologies, California, USA) supplemented with 10% 
FSB and seeded in 24-well plates and cultured overnight at 
37 °C with 5% CO2. Ten-fold serial dilutions of the samples 
were performed using α-MEM and used to infect BHK-21 
cells at 37 °C for 1 h. After this period, 1% carboxymethyl 
cellulose in α-MEM with 2% FBS was added and the cells 
were kept in culture at 37 °C with 5% CO2 for five days. 
Then, the cells were fixed with formaldehyde 4% and the 
plaque was visualized by staining with crystal violet (1% 
crystal violet powder (m/v), 20% MeOH and H2O).
HPLC-DAD analysis
HPLC analyses were performed in an Agilent Series 
1260 equipment with quaternary pump, autosampler, 
and diode array detector (DAD) (Agilent Technologies, 
Wilmington, USA) with a LiChrospher RPC18 LiChrocart 
column (4.6 × 250 mm, 5 μm) (Merck, Frankfurt, Germany) 
coupled to a precolumn SupelguardTM LC-18 (4.0 × 20 mm, 
5 μm) (Merck, Frankfurt, Germany). The flow rate was 
0.8 mL min-1, the injection volume was 10 μL, and the 
column oven temperature was set to 40 °C. The sample 
concentrations in MeOH were 20 mg mL-1 for the defatted 
extract and 2 mg mL-1 for the compound 1. Prior to the 
injection, the samples were filtered through a 0.45 μm 
Chromafil R Xtra PVDF membrane (Macherey-Nagel, 
Düren, Germany). The runs were monitored at 225 nm, and 
the DAD was set to an acquisition range of 190-400 nm. The 
data were gathered using the OpenLAB CDS ChemStation 
Edition software (Agilent Technologies). Ultrapurified 
water, adjusted to pH 3 with HCOOH (A), and ACN (B) 
were used in varying proportions as the mobile phase. The 
analysis conditions assayed were: 10-20% B, 0-5 min; 
20-22% B, 5-10 min; 22-24% B, 10-15 min; 24-26% B, 
15-20 min; 26-28% B, 20-25 min; 28-30% B, 25-30 min, 
and, finally, 30-100% B, 30-35 min.
SPE procedures 
The SPE in analytical scale was performed in 
C18 cartridges (500 mg, 3 mL) (Applied Separations, 
Allentown, USA) and in semi-preparative scale was 
performed in a 30 mL plastic syringe filled with silica 
gel C18 (40-63 μm, Merck, Frankfurt, Germany) 
2.7 cm inner diameter × 3.2 cm bed high). Both systems 
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were coupled to a 12 ports VisiprepTM SPE Vacuum 
Manifold DL (Supelco, St. Louis, USA). The analytical 
scale SPE cartridges were previously activated with 5 mL 
of ACN, followed by conditioning with 5 mL of ACN/H2O 
mixture at the same composition assayed in the first elution. 
The flow rate was maintained between 1.5 and 3 mg mL-1. 
The defatted crude extract has been loaded in an aliquot of 
1 mL from a 10 mg mL-1 solution prepared using the same 
ACN/H2O proportion used in the first elution. The organic 
solvent was removed from the eluted fractions under reduced 
pressure at 37 °C and the water residues were freeze-dried. 
The optimized SPE procedure in analytical scale was defined 
as activation step: 5 mL of ACN; conditioning step: 5 mL 
of 10% ACN; sample application: 1 mL of defatted crude 
extract in 10% ACN; elution steps: (E1) 9 mL of 10% ACN, 
(E2) 9 mL of 15% ACN, (E3) 9 mL of 20% ACN, (E4) 3 mL 
of 24% ACN, (E5) 3 mL of 28% ACN, (E6) 3 mL of 
30% ACN and washing step (E7) 3 mL of ACN.
In the SPE procedures in semi-preparative scale the 
phase (10 g) was applied as a suspension in ACN, with 
the pressure adjusted to 50 kPa below the atmospheric 
pressure. The total mobile phase volume assayed for each 
SPE step was adjusted considering the ratio between the 
elution volumes and the bed volume used on analytical 
scale. Thus, SPE procedure in semi-preparative scale was 
defined as activation step: 60 mL of ACN; conditioning 
step: 60 mL of 10% ACN; sample application: crude MeOH 
leaf extract (100 mg) applied onto the column adsorbed 
in a small amount of the stationary phase; elution steps: 
(E1) 180 mL of 10% ACN (collected in three sub-fractions 
of 60 mL-E1.1, E1.2 and E1.3); (E2) 180 mL of 15% ACN 
(collected in three sub-fractions of 60 mL-E2.1, E2.2 
and E2.3); (E3) 180 mL of 20% ACN (collected in three 
sub-fractions of 60 mL-E3.1, E3.2 and E3.3); (E4) 60 mL 
of 24% ACN, (E5) 60 mL of 28% ACN, (E6) 60 mL of 
30% ACN and washing step (E7) 60 mL of ACN. The 
experiments were performed six times in parallel (total 
of crude extract = 600 mg). The correspondent fractions 
from the parallel experiments were combined by TLC 
similarities, the organic solvent was removed under low 
pressure at 37 °C and the water residues were freeze-
dried. Compounds 1, 2 and 3 were selectively isolated 
from E3.2-E3.3, E6 and E2.2-E2.3 + E3.1 fractions, 
respectively. The TLC and 1H NMR profiles of the E1.1 and 
E1.2 fractions revealed non-alkaloidal polar compounds. 
The amounts of the combined fractions are shown in 
Supplementary Information (SI) section, Table S1.
HPLC-DAD-MS/MS analysis
The HPLC-DAD-MS/MS analyses were carried out 
in an Alliance 2695 Waters (Waters Cop., Milford, USA) 
equipment with a quaternary pump, autosampler, degasser, 
column oven, diode array detector and equipped with a 
Phenomenex Luna C18(2) column (Phenomenex, Torrance, 
USA) (150 × 4.6 mm, 3 μm) with a Waters Nova-Pack 
C18 guard column (10 × 3.9 mm, 4 μm) (Waters Cop., 
Milford, USA). A previously reported gradient program 
was employed:30 AcOH-H2O (0.5:99.5 v/v) (phase A) and 
MeOH (phase B). The applied elution conditions were: 
0-2 min, 0% B isocratic; 2-6 min, linear gradient from 0 
to 15% B; 6-12 min, 15% B isocratic; 12-17 min, linear 
gradient from 15 to 20% B; 17-35 min, 20% B isocratic; 
35-90 min, linear gradient from 20 to 35% B; 90-136 min, 
35% B isocratic, and finally, washing and reconditioning of 
the column was done. The diode array detector was set at an 
acquisition range of 250-600 nm and phenolic compound 
monitoring was performed at 280, 320 and 370 nm. The 
injection volume was 50 μL. The online MS were obtained 
on a Micromass (Waters Cop., Milford, USA). Quattro 
micro triple quadrupole mass spectrometer coupled to the 
exit of the diode array detector and equipped with a Z-spray 
electrospray ionization (ESI) source. A flow of 70 μL min-1 
from the DAD eluent was directed to the ESI interface using 
a flow-splitter. Nitrogen was used as desolvation gas, at 
300 ºC and a flow rate of 450 L h-1, and no cone gas was 
used. A potential of 3.2 kV was used on the capillary for 
positive ion mode and 2.6 kV for negative ion mode. The 
source block temperature was held at 120 ºC. Full scan 
mass spectra (MS), within the m/z range 50-1000, were 
performed in the positive mode at different cone voltages 
(15, 30 and 45 V) and in the negative mode at -30 V. 
MS/MS product ion spectra in positive and negative 
modes were recorded using argon as collision gas at 
1.5 × 10-3 mbar and under different collision energies in 
the range 10-40 eV and -30 V (for negative) and optimized 
(for positive polarity) cone voltages. The optimum cone 
voltages were those which produced the maximum intensity 
for protonated molecule [M + H]+ and protonated aglycone 
ion [Y0]+ in the previous MS experiments. The flavonoid 
aglycone fragment ions have been designed according to 
the nomenclature proposed by Ma et al.31
Results and Discussion
In order to evaluate the antiviral activity and the 
cytotoxicity of the crude MeOH extract of P. leiocarpa 
leaves, infected and uninfected HepG2 cells were treated 
with 50 μg mL-1 of the extract and assessed cell survival 
after 48 h by the MTT assay. DENV-2 infection promoted 
a reduction of about 55% of HepG2 viability in untreated 
condition. This reduction was less prominent when cells 
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were infected and treated with the extract showing 28% 
of reduction (Figure 1a). Viability of non-infected HepG2 
treated with the extract was only slightly decreased, 
remaining almost 90% of viable cell. Quantification of 
DENV-2 at the conditioned medium of infected HepG2 
after 48 h demonstrated a reduction of about 80% of DENV 
infectious particles when it was treated with the extract 
comparing with untreated condition (Figure 1b). These 
results indicate that compounds present in the MeOH 
extract of P. leiocarpa leaves have an efficient antiviral 
activity against DENV-2.
SPE method developing 
The previously described isolations of the monoterpene 
indole alkaloids from P. leiocarpa leaves employed several 
classic methodological approaches such as liquid-liquid or 
acid-base partition followed by chromatography column 
(CC) in normal or reversed-phase and prep-TLC or semi-
prep HPLC.6,12,14,15 Aiming to optimized the isolation 
of these alkaloids probably present in our anti-dengue 
bioactive MeOH extract of P. leiocarpa, we seek for a one-
step isolation procedure based on our previously described 
expertise.22,25 The first approach to access the chemical 
profile of the bioactive extract was made by TLC, showing 
three major spots under 254 nm and a fourth spot (more 
polar compounds), besides those three, after derivatization 
with anisaldehyde/H2SO4. The HPLC-DAD profile of the 
defatted extract (MeOH/H2O 1:3 v/v fraction) revealed 
three peaks with UV spectra compatible to those of indole 
alkaloids (λMAX 221-225 nm).12,32 The parameters extracted 
from this HPLC chromatogram: mobile phase composition 
and elution volume of each peak (Table 1) were used 
to establish the initial levels of the SPE operational 
variables.22,25 
The monoterpene indole alkaloid N,β-D-glucopyranosyl 
vincosamide (1), previously isolated by classical methods 
(see isolation details in SI section), was used as reference 
compound (Figure S1 in SI section). Based on the mobile 
phase composition range in which the constituents of the 
defatted extract had been eluted (20% ACN/H2O v/v to 
100% ACN), the following mobile phase compositions 
were applied: 20-30% ACN/H2O (v/v) and a final 
washing step with 100% ACN. The elution volumes of 
each compound were evaluated as bed volume (Vbed) 
units (Velution/Vbed) (Table 1). However, the differences of 
the physico-chemical characteristics between the HPLC 
stationary phase (14% carbon, 5 μm particle size) and 
that of the SPE cartridge (18% carbon, 40-60 μm particle 
size) led us to employ elution volumes smaller than that 
of the less retained compound (6.6 × Vbed) since we could 
expect a smaller retention of the compounds in the SPE 
cartridge (stationary phase with less packing). Thus, the 
established elution volume was three times the bed volume 
(3 × 1 mL) and a first SPE experiment was designed: 
(E1) 3 mL of 20% ACN, (E2) 3 mL of 24% ACN, (E3) 3 mL 
of 28% ACN, (E4) 3 mL of 30% ACN and washing step 
(E5) 3 mL of ACN. The TLC monitoring of the yielded 
fractions evidenced the selectivity of the chromatographic 
system for the eluted compound(s) in E1 and E3 fractions. 
However, the eluted compound in E1 fraction also appeared 
distributed along the E2 to E4 elution steps.
This first SPE procedure was then modified to promote 
a better separation of the compounds by using less strong 
initial eluotropic ACN/H2O mixtures: 10 and 15% ACN and 
by increasing the elution volume to three times (3 × 3 mL). 
These optimizations showed to be effective separating 
the three indole alkaloids and besides, one fraction rich 
in more polar compounds. A one-step semi-preparative 
scale-up of isolation (directly from the crude extract) 
was then designed applying some necessary adjustments. 
Table 1. HPLC parameters from the major constituents of the defatted 
extract (MeOH/H2O 1:3 fraction) of Psychotria leiocarpa leaves
tR / min ACN / % Velution / mL Velution/Vbeda
2.3 20 1.8 0.4
3.4 20 2.7 0.6
16.8 24 13.4 3.2
34.9 100 27.9 6.6
tR: retention time; ACN: acetonitrile; Velution: elution volume; Vbed: bed 
volume; aVbed = π × r2 × L = 3.14 × (0.23)2 × 25 = 4.1 cm3 (ca. 4.1 mL).
Figure 1. Cytoprotective and antiviral effect of the MeOH extract from 
Psychotria leiocarpa leaves (PLM). HepG2 cells were infected with 
DENV2 16681 or not, then treated with 50 μg mL-1 of the extract. Black 
bars indicate DENV2 16681 infected cells and white bars uninfected 
cells. (a) Cell viability was assessed by MTT assay 48 h post infection 
and results are expressed in percentage of the metabolization of untreated 
and uninfected HepG2 (control). Non-infected and treated conditions were 
used as control of cytotoxicity and cell proliferation. (b) Determination of 
DENV loads in the conditioned medium by plaque assay. The experiments 
were performed in triplicate of three independent biological replicates and 
plotted as mean ± standard error (S.E.M.).
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A homemade cartridge with 10 g of RP-C18 stationary 
phase (3.0 × 2.7 cm, 15-25 μm, Vbed = ca. 20 mL) loaded 
with 100 mg of the crude extract, which was adsorbed 
in a small amount of stationary phase instead of the use 
of 20 mL of sample solution (to avoid early elution of 
the constituents on the applying sample step), was used. 
The first three steps of elution were collected in three 
sub-fractions of 20 mL (total = 60 mL; 3 × Vbed). The 
entire process generated 13 fractions, which showed by 
their TLC profiles the efficacy of the developed method. 
The experiment was replicated six times in parallel (total 
of the crude extract = 600 mg) (Table S1 in SI section). 
Compounds 1 (40.7 mg), 2 (18.4 mg) and 3 (56.5 mg) 
(Figure 2) were selectively isolated from E3.2-E3.3, E6 and 
E2.2-E2.3 + E3.1 fractions, respectively, with high purity, as 
shown by HPLC-UV and 1H NMR analyses. Their chemical 
structures were elucidated based upon 1D and 2D NMR, 
UV, HRMS, and comparison to literature data.6,12,33 
Compounds 4-8 (Figure 2) were characterized online by 
HPLC-DAD-MS/MS in the combined E1.1-E1.2 fractions 
(314.6 mg) (Tables 2 and 3, Figure 3), which showed also 
to contain free sugars (data not shown).
Anti-dengue activity of compounds 1-3 and polyphenolic-
rich fraction
The isolated monoterpene indole alkaloids (1-3) and 
the polyphenolic-rich fraction from the MeOH extract of 
P. leiocarpa leaves were used to treat non-infected and 
infected HepG2 and, cell viability was determined after 
48 h (Figure 4). It was showed that strictosidinic acid (3), 
N-glucopyranosyl vincosamide (1) and the polyphenolic-
rich fraction were non-cytotoxic in HepG2, preserving cell 
viabilities in about 98, 94 and 107% (proliferative effect), 
respectively, comparing to untreated non-infected HepG2. 
However, vincosamide (2) promoted a reduction of HepG2 
viability, resulting in about 83% viable cells, being more 
cytotoxic than the crude extract (Figures 1a and 4a). Despite 
these differences, the treatment of infected HepG2 cells 
with compounds 1-3 and the polyphenolic-rich fraction 
promotes a protective effect from DENV induced cell death 
(about 74, 74, 83 and 88% of cell viability, respectively), 
compared with untreated infected HepG2 (about 45% 
of cell viability) (Figure 4a). In addition, quantification 
of DENV in HepG2 culture showed that treatment with 
compounds 1-3 promoted a reduction on DENV infectious 
particles in the conditioned medium (Figure 4b). The 
highest reduction in viral load was observed when 
infected HepG2 was treated with vincosamide (2) (99% 
Table 2. HPLC-DAD-MS/MS data of the identified flavonol triglycerides from Psychotria leiocarpa leaves
tR / min Compound UV λMAX / nm
MS1 MS2
Parent ion [M + H]+ 
m/z




20.15 quercetin-hex-hex-hex (4) 253, 353 789 627 465 303
22.97 kaempferol-hex-hex-hex (5) 265, 346 773 611 449 287
For the correspondent chromatogram see Figure 3. tR: retention time; hex: hexose. See SI section for MS2 ions from [Y0]+.
Table 3. HPLC-DAD-MS/MS data of the identified caffeoylquinic acids (CQA) from Psychotria leiocarpa leaves
tR / min Compound UV λMAX / nm
MS1 MS2
Parent ion [M - H]– m/z (RA / %) Secondary ions m/z (RA / %)
15.22 3-CQA (6) 296, 317 353 (100) 191 (100), 179 (ca. 75)
22.60 5-CQA (7) 298, 325 353 (75) 191 (100), 179 (< 5)
24.87 4-CQA (8) 302, 325 353 (100) 191 (50), 179 (60); 173 (100)
For the correspondent chromatogram see Figure 3. tR: retention time; RA: relative abundance.
Figure 2. Chemical structures of the isolated monoterpene indole alkaloids 
(1-3) and of the characterized flavonols (4, 5) and caffeoylquinic acids 
(CQA) (6-8) from the leaves of Psychotria leiocarpa.
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of reduction). However, it cannot be excluded that its 
effect has been determined by the compound cytotoxicity. 
The polyphenolic-rich fraction showed the lowest anti-
DENV effect with only 30% of infectious particles 
reduction (Figure 4b), which could indicate that its higher 
cytoprotective effect observed in DENV infected HepG2 
(Figure 4a) was mainly associated to its proliferative effect.
Vincosamide (2) with moderate cytotoxicity at 
50 μg mL-1 but high reduction on DENV infectious 
particles (Figure 4b) was tested at 25 μg mL-1 (Figure 5) 
in order to evaluate the dose-effect on cytotoxicity and on 
its cytoprotection on DENV infection in HepG2 culture. 
This lower dose was non-cytotoxic to non-infected HepG2 
cells (viability of 94% when compared to the control). The 
ability to reduce DENV-induced cell death was preserved. 
The mortality after infection dropped from 55 to 26% 
with treatment, similar to the one observed with the use of 
50 μg mL-1 (Figure 4a). These results indicate the potential 
of vincosamide (2) as anti-dengue agent, despite its relative 
cytotoxicity.
Polyphenol compounds
The HPLC-DAD chromatogram of the combined 
E.1.1-E1.2 fractions from the semi-preparative SPE 
experiment (Table S1 in SI section) is shown in Figure 3.
The identification of the phenolic compound for which 
the standard was available was carried out by comparing 
its retention time (tR), UV-Vis spectrum, MS recorded in 
full scan and MS/MS product ion scan mode with those 
of the standard analyzed under the same conditions. The 
identity of the other compounds was elucidated using the 
Figure 3. HPLC-DAD profile at 320 nm of the combined E1.1-E1.2 fractions yielded from the semi-prep SPE experiments from the bioactive extract of 
Psychotria leiocarpa.
Figure 4. Cytoprotective and antiviral effect of monoterpene indole alkaloids (1-3) and of the polyphenolic-rich fraction (PRF). HepG2 cells were infected 
with DENV2 16681 or not, then treated with 50 μg mL-1 of the extract. Black bars indicate DENV2 16681 infected cells and white bars uninfected 
cells. (a) Cell viability was assessed by MTT assay 48 h post infection and results are expressed in percentage of the metabolization of untreated and 
uninfected HepG2 (control). Non-infected and treated conditions were used as control of cytotoxicity and cell proliferation. (b) Viral quantification in the 
conditioned medium of infected cells by plaque assay. The experiments were performed in triplicate of three independent biological replicates and plotted 
as mean ± standard error (S.E.M.).
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UV-Vis spectra to assign the phenolic class,34 the MS full 
scan spectra in positive and negative modes to identify the 
[M + H]+ and [M - H]– ions, the MS/MS product ion spectra 
using the [M + H]+ ion as precursor to assign the protonated 
aglycone [Y0]+ and fragmentations observed in both 
MS/MS product ion spectra using [M + H]+ or [Y0]+ or 
[M - H]–. Loss of 132, 146 or 162 Da would be an indicative 
of the presence of pentose, deoxyhexose or hexose, 
respectively. Additionally, the chromatographic elution 
order aided in some structural assignments as previously 
described.35 The five identified polyphenolic compounds 
are shown in Figure 2. 
Two flavonol triglycosides were detected: peaks 
with tR = 20.15 min (UV λMAX = 253, 267, 353 nm) and 
tR = 22.97 min, (UV λMAX = 265, 346 nm). The first one 
(tR = 20.15 min) showed protonated and deprotonated 
molecular ions detected in MS1 scan spectra in positive 
and negative modes at m/z 789 and 787, respectively. The 
ESI(+)-MS/MS product ion spectrum obtained using as 
precursor ion the protonated aglycone [Y0]+ (m/z 303) 
revealed the characteristic fragmentation pattern of 
quercetin aglycone.34 The ESI(+)-MS/MS product ion 
spectrum obtained using as precursor the [M + H]+ ion 
showed a successive losses of three hexose residues (m/z 627, 
465 and 303) (Figure S2 in SI section). The second one 
(tR = 22.97 min) showed protonated and deprotonated 
molecular ions detected in MS1 scan spectra in positive 
and negative modes at m/z 773 and 771, respectively. The 
ESI(+)-MS/MS product ion spectrum obtained using as 
precursor ion the protonated aglycone [Y0]+ (m/z 287) 
revealed the characteristic fragmentation pattern of 
kaempferol aglycone.34 The ESI(+)-MS/MS product ion 
spectrum obtained using as precursor the [M + H]+ ion 
showed a successive losses of three hexose residues (m/z 
611, 449 and 287) (Figure S3 in SI section). Flavonol di- 
and monoglycosides were reported from Psychotria spp.,3 
however, to the best of our knowledge, it is the first time that 
flavonol triglycosides are described in the genus Psychotria.
The UV spectra of the compounds related to the 
chromatographic peaks with tR = 15.22 min (λMAX = 296, 
317 nm); tR = 22.60 min (λMAX = 298, 325 nm) and 
tR = 24.87 min (λMAX = 305, 325 nm) suggested the 
presence of hydroxycinnamic acid derivatives. The MS 
fragmentation patterns of these peaks were very similar. 
All of them presented protonated and deprotonated 
molecular ions detected in MS1 scan spectra in positive 
and negative modes at m/z 355 and 353, respectively. In 
addition to these ions, they showed in positive mode the 
ions at m/z 163 and 173 and, in negative mode, the ion at 
m/z 191. These data suggested the presence of three isomers 
of the caffeoylquinic acid (CQA) (chlorogenic acid).35 To 
discriminate the isomers, their ESI(+)-MS/MS product ion 
spectra using a collision energy of 20 eV were analyzed 
by using as precursor ion the deprotonated molecular ion 
[M - H]– (m/z 353). The peak with tR = 22.60 min presented 
retention time, UV spectrum and MS/MS fragment ions at 
m/z 191 (100) and 179 (< 5), similar to the 5-CQA standard 
injected under the same conditions. The elution order in 
reversed-phase (C18) for the four possible isomers: 1-CQA, 
3-CQA, 4-CQA and 5-CQA depends on the number of 
free equatorial hydroxyl groups in the quinic moiety.36 So, 
1- and 3-CQA with two free equatorial hydroxyl groups 
are more hydrophilic and elute before than 4- and 5-CQA 
isomers (which have just one equatorial hydroxyl group 
each). Thus, the peak with tR = 24.87 min is probably the 
4-CQA and the peak with tR = 15.22 min might be 1- or 
3-CQA. In addition, an intense, usually base peak, fragment 
ion at m/z 173, corresponding to dehydration of quinic acid 
fragment is preferred for an acyl substituent at C4,35,37 which 
confirm that peak with tR = 24.87 min (MS/MS fragment 
ions at m/z 191 (50), 179 (60), 173 (100)) is the 4-CQA. 
Peak with tR = 15.22 min presents MS/MS fragment 
ions at m/z 191 (100) and 179 (ca. 75) compatible to the 
MS/MS fragmentation profile of the 3-CQA.37 This is the 
first time that caffeoylquinic acids are described in the 
genus Psychotria.
Conclusions
The in vitro non-cytotoxicity and anti-dengue virus 
serotype 2 (DENV2) activity of the MeOH extract 
Figure 5. Cell viability of HepG2 after treatment with lower dose of 
vincosamide (2). HepG2 cells were infected with DENV2 16681 or not, 
then treated with 25 μg mL-1 of the compound. Black bars indicate DENV2 
16681 infected cells and white bars uninfected cells. Cell viability was 
assessed by MTT assay 48 h post infection and results are expressed in 
percentage of the metabolization of untreated and uninfected HepG2 
(control). Non-infected and treated condition was used as control of 
cytotoxicity and cell proliferation. The experiment was performed in 
triplicate of three independent biological replicates and plotted as mean 
± standard error (S.E.M.).
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of P. leiocarpa leaves and of its monoterpene indole 
alkaloids 1-3 were herein described. Vincosamide (2) 
with a preliminary dose-dependent activity inhibiting 
at 50 μg mL-1 99% of DENV infectious particles in the 
conditioned medium of infected HepG2 culture can be 
highlighted among the other isolated alkaloids as a potential 
anti-dengue agent. An efficient one-step SPE method for 
isolating the alkaloids 1-3 was developed which allowed 
optimizing the previously described costly and time-
consuming steps of their isolation. The semi-prep scale-
up of this isolation was able to successfully reproduce 
the results obtained in the analytical scale allowing 
purifying larger amounts of the bioactive compounds for 
further studies. Compound 3 was isolated for the first 
time from the species. The methodology has also allowed 
yielding a polyphenolic-rich fraction which contained two 
flavonol triglycosides (4, 5) and three caffeoylquinic acid 
isomers (6-8), all of them characterized for the first time 
in the genus Psychotria.
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